Modulation of antibody affinity by a non‐contact residue

Protein Science - Tập 2 Số 2 - Trang 206-214 - 1993
Joel F. Schildbach1, Richard I. Near2, Robert E. Bruccoleri3, Edgar Haber4, P.D. Jeffrey3, Jiřı́ Novotný3, S. Sheriff3, Michael N. Margolies2,5
1Program on Immunology, Harvard University Graduate School of Arts and Sciences, Cambridge, Massachusetts 02138
2Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114
3Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543
4Cardiovascular Biology Laboratory, Division of Biological Sciences, Harvard School of Public Health, Boston, Massachusetts 02115
5Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114

Tóm tắt

AbstractAntibody LB4, produced by a spontaneous variant of the murine anti‐digoxin monoclonal antibody 26–10, has an affinity for digoxin two orders of magnitude lower than that of the parent antibody due to replacement of serine with phenylalanine at position 52 of the heavy chain variable region (Schildbach, J.F., Panka, D.J., Parks, D.R., et al., 1991, J. Biol. Chem. 266, 4640–4647). To examine the basis for the decreased affinity, a panel of engineered antibodies with substitutions at position 52 was created, and their affinities for digoxin were measured. The antibody affinities decreased concomitantly with increasing size of the substituted side chains, although the shape of the side chains also influenced affinity. The crystal structure of the 26–10 Fab complexed with digoxin (P.D.J., R.K. Strong, L.C. Sieker, C. Chang, R.L. Campbell, G.A. Petsko, E.H., M.N.M., & S.S., submitted for publication) shows that the serine at heavy chain position 52 is not in contact with hapten, but is adjacent to a tyrosine at heavy chain position 33 that is a contact residue. The mutant antibodies were modeled by applying a conformational search procedure to position side chains, using the 26–10 Fab crystal structure as a starting point. The results suggest that each of the substituted side chains may be accommodated within the antibody without substantial structural rearrangement, and that none of these substituted side chains are able to contact hapten. These modeling results are consistent with the substituents at position 52 having only an indirect influence upon antibody affinity. The mutagenesis and modeling results suggest that even conservative replacements of non‐contact residues can alter affinity indirectly through their impact on contact residue placement.

Từ khóa


Tài liệu tham khảo

10.1002/j.1460-2075.1990.tb07598.x

10.1126/science.2426778

10.1002/jcc.540040211

10.1002/bip.360260114

10.1073/pnas.86.14.5532

10.1038/342877a0

10.1042/bj0890114

10.1126/science.1900953

10.1002/prot.340050404

10.1038/321522a0

Kabat E.A., 1991, Sequences of Proteins of Immunological Interest

10.1093/protein/4.7.773

10.1073/pnas.82.2.488

Lavoie T.B., 1992, Experimental analysis by site‐directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme, J. Immunol., 148, 503, 10.4049/jimmunol.148.2.503

10.1016/0022-2836(91)90617-F

Mudgett‐Hunter M., 1982, High‐affinity monoclonal antibodies to the cardiac glycoside, digoxin, J. Immunol., 129, 1165, 10.4049/jimmunol.129.3.1165

10.1016/0076-6879(83)92044-X

Near R.I., 1991, The specificity properties that distinguish members of a set of homologous anti‐digoxin antibodies are controlled by H chain mutations, J. Immunol., 146, 627, 10.4049/jimmunol.146.2.627

10.1016/0161-5890(90)90157-U

10.1021/bi00437a034

10.1002/prot.340070203

10.1073/pnas.72.3.819

10.1073/pnas.86.15.5938

10.1073/pnas.85.9.3080

10.1038/332323a0

Sambrook J., 1989, Molecular Cloning

10.1016/0022-2836(86)90245-7

Schildbach J.F.(1992).An analysis of structural complementarity and specificity of an anti‐digoxin antibody using mutagenesis and molecular modeling. Ph.D. thesis Harvard University Cambridge Massachusetts.

Schildbach J.F., 1991, Altered hapten recognition by two anti‐digoxin hybridoma variants due to variable region point mutations, J. Biol. Chem., 266, 4640, 10.1016/S0021-9258(20)64370-8

10.1016/0022-2836(87)90124-0

10.1073/pnas.84.22.8075

10.1073/pnas.82.6.1697

10.1038/nbt0391-266

10.1126/science.2451287

10.1016/0079-6107(72)90005-3